# Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis

> **NCT05238181** · — · UNKNOWN · sponsor: **National Cheng-Kung University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Autoimmune Diseases
- Helicobacter Pylori Gastritis
- Anemia, Pernicious
- Metaplasia
- Gastritis, Atrophic

## Interventions

- **DIAGNOSTIC_TEST:** Assess pyloric or pseudopyloric metaplasia of corpus by H&E stains
- **DIAGNOSTIC_TEST:** Assess pyloric or pseudopyloric metaplasia of corpus by TFF2 immunohistochemistry stains
- **DIAGNOSTIC_TEST:** The assessment of corpus-predominant gastritis index (CGI), Operative Link for Gastritis Assessment (OLGA), and Operative Link on Gastric Intestinal Metaplasia assessment (OLGIM)

## Key facts

- **NCT ID:** NCT05238181
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05238181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05238181, "Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05238181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*